drugset / Trial / NCT04256525
Prophylactic Anticoagulation for Catheter-related Thrombosis
RandomizedParallel-groupOpen-labelPrevention
Summary
The main objective of this study is to compare the efficacy and safety of aspirin, low molecule heparin and rivaroxaban for preventing catheter-related thrombosis in middle-to-high-risk ambulatory patients with cancer and implantable venous access ports.
Timeline
- Start
- 2020-05-01
- Primary completion
- 2021-08-30
- Completion
- 2022-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 100 mg | Oral |
| Subject | Rivaroxaban | Other / unclassified | 10 mg | Oral |
| Subject | low molecule heparin | Unknown | 0.4 ml | Subcutaneous |